Dosso, S. D. A Rational Sequencing of Anti-Angiogenic Agents as Second-Line Treatment Choice for mCRC Patients Progressing After a Bevacizumab-Based First Line. THE HEALTHBOOK COMPANY LTD.
Chicago Style (17th ed.) CitationDosso, Sara De. A Rational Sequencing of Anti-Angiogenic Agents as Second-Line Treatment Choice for MCRC Patients Progressing After a Bevacizumab-Based First Line. THE HEALTHBOOK COMPANY LTD.
MLA (9th ed.) CitationDosso, Sara De. A Rational Sequencing of Anti-Angiogenic Agents as Second-Line Treatment Choice for MCRC Patients Progressing After a Bevacizumab-Based First Line. THE HEALTHBOOK COMPANY LTD.
Warning: These citations may not always be 100% accurate.